The National Institute of Mental Health has renewed its support for UCLA’s collaborative Center for HIV Identification, Prevention and Treatment Services, or CHIPTS, with a five-year, $7.5 million grant. The… read more.
One in three new mothers during early COVID-19 screened positive for postpartum depression — nearly triple pre-pandemic levels — and 1 in 5 had major depressive symptoms, say… read more.
Exposure to ozone from air pollution has been linked to an increase in depressive symptoms for adolescents over time, even in neighborhoods that meet air quality standards, according… read more.
Depression and other mental health outcomes are similar for men choosing different options for initial treatment of localized prostate cancer, reports a study in The Journal of Urology®, an… read more.
A recently published extensive systematic review showed a 28% reduction in mental health service use in the early phase of the COVID-19 pandemic among children and young people…. read more.
Have you ever felt uncomfortable when asked about depression or any other sensitive personal issue when checking in for a medical visit? You’re not alone. Doctors at Wake… read more.
A decades-long New Zealand national data base study suggests an association between mental disorders and subsequent dementia. The findings were published on February 16, 2022 in JAMA Psychiatry…. read more.
Eating disorders are associated with an increased risk of people with diabetes developing diabetic retinopathy — a condition that can cause blindness if untreated — according to new… read more.
Ketamine is effective for the acute treatment of severe suicidal ideation, researchers reported on February 2, 2022 in The BMJ/British Medical Journal. “This study confirmed in a large… read more.
COVID-19 has had a devastating impact on people’s physical and mental health and has caused economic hardship. However, this adversity has disproportionately hurt certain populations—including essential workers and… read more.
COLUMBIA, Mo. – Older adults with dementia or mild cognitive impairment sometimes struggle to remember daily tasks, including managing medications, shopping for groceries and tracking upcoming events, including… read more.
Biogen Inc. and Eisai Co., Ltd. provided an important update on the continuing progress of the Phase IV post-marketing confirmatory study of Aduhelm (aducanumab-avwa) 100 mg/mL injection for… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
